Clinical trials: Objectified Gastroesophageal Reflux Disease
Patients With Persistent Objectified Gastroesophageal Reflux and Reflux-Associated Symptoms Despite PPI-Therapy With 40mg Esomeprazole
High Dosage Esomeprazole and Baclofen for Therapy of Gastroesophageal Reflux Disease
It has been reported that Baclofen is an appropriate tool in the therapeutic management of Gastroesophageal Reflux Disease. To objectify gastroesophageal reflux combined pH-metry/impedance monitoring was applied to patients with…
- Trial name
- NEXBAC (NCT00461604)
- Where
- Germany
- Volunteers
- 40 people
- Sponsor
- Technical University of Munich
Atypical Gastroesophageal Reflux Symptoms, Objectified Gastroesophageal Reflux Disease
Effect of Full-thickness Gastroplication With the GERD-X System on Atypical Gastro-esophageal-reflux-symptoms
Patients with atypical symptoms of objectified gastroesophageal reflux disease will be treated by full-thickness gastroplication and the effect of this intervention will be measured by questionnaires and clinical diagnostics (for…
- Trial name
- NCT02181855
- Testing
- Full-thickness gastroplication (GERD-X)
- Where
- 4 sites in Austria, Germany
- Volunteers
- 23 people
- Sponsor
- Technical University of Munich